Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-chlorotaurine is a long-lived oxidant and the N-chloro derivative of the amino acid taurine, naturally produced by activated human granulocytes and monocytes as part of the immune response[1][3]. It acts as a mild oxidizing antiseptic with broad-spectrum antimicrobial activity against bacteria, fungi, viruses (including SARS-CoV-2, influenza viruses, RSV), and parasites[3][8]. Its mechanism involves chlorination and oxidation of pathogen proteins and enzymes, leading to inactivation of virulence factors (microbiostatic effect), loss of pathogen viability or virulence (post-antibiotic effect), and delayed regrowth[6][8]. Additionally, it inhibits inducible nitric oxide synthase and IkappaB kinase[2][4], contributing to its anti-inflammatory properties. N-chlorotaurine can be synthesized chemically for topical application at various body sites (e.g., eye, skin ulcers, ear canal, nasal sinuses) with excellent tissue tolerability demonstrated in Phase I/II studies for conditions such as external otitis, skin ulcerations, keratoconjunctivitis, conjunctivitis, acanthamoeba keratitis[3][5]. C-methylated derivatives have been developed for improved stability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-chlorotaurine.